CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Clinical trial NCT07441291 · RECRUITING

Trial details

NCT number: NCT07441291
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

B ALL Allogenetic Hematopoietic Stem Cell Transplantation MRD-positive

Start date: 2025-11-30
Primary completion: 2027-12-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.